Drug class
Antiarrhythmic - Class IC
Antiarrhythmic - Class IC is a therapeutic drug class under the Vaughan-Williams classification consisting of potent sodium-channel blockers, such as flecainide and propafenone. Read more about Antiarrhythmic - Class IC
33 drugs in this class 24 manufacturers
Drugs in Antiarrhythmic - Class IC
PROPAFENONE HCL
PROPAFENONE HCL ER (propafenone HCl)
PROPAFENONE HCL
FLECAINIDE ACETATE
FLECAINIDE ACETATE
FLECAINIDE ACETATE
PROPAFENONE HCL ER (propafenone HCl)
PROPAFENONE HCL ER (propafenone HCl)
Antiarrhythmic - Class IC is a therapeutic drug class under the Vaughan-Williams classification consisting of potent sodium-channel blockers, such as flecainide and propafenone.
These agents exert their primary electrophysiological effect by strongly inhibiting fast inward cardiac sodium currents with slow dissociation kinetics, significantly depressing phase 0 depolarization and slowing intracardiac conduction while having minimal effect on action potential duration.
Clinically, Class IC drugs are primarily utilized for the termination and rhythm-control maintenance of supraventricular arrhythmias, including atrial fibrillation, atrial flutter, and paroxysmal supraventricular tachycardias, as well as selected life-threatening ventricular arrhythmias in patients without structural or ischemic heart disease.
-
nih.gov
Antiarrhythmic - Class IC is a therapeutic drug class under the Vaughan-Williams classification consisting of potent sodium-channel blockers, such as flecainide and propafenone
-
fda.gov
These agents exert their primary electrophysiological effect by strongly inhibiting fast inward cardiac sodium currents with slow dissociation kinetics, significantly depressing phase 0 depolarization and slowing intracardiac conduction while having minimal effect on action potential duration
-
nih.gov
Clinically, Class IC drugs are primarily utilized for the termination and rhythm-control maintenance of supraventricular arrhythmias, including atrial fibrillation, atrial flutter, and paroxysmal supraventricular tachycardias, as well as selected life-threatening ventricular arrhythmias in patients without structural or ischemic heart disease
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.